Statistics
Publications
27
Citations
2.3K
H-Index
23
Active since
2001
Nigel J. Parr is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, oncology, and pharmacology.
Publications per year
2001–2021
27
27
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
S. Picaud, O. Fedorov, Angeliki Thanasopoulou et al. · Cancer Research · 2015 · 230 citations · Full text
Medicine, Oncology, Pharmacology +13
Sarina A. Piha‐Paul, Christine L. Hann, Christopher A. French et al. · JNCI Cancer Spectrum · 2019 · 207 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 27